Institutional investors purchased a net $1.8 million shares of KERX during the quarter ended September 2013 and now own 63.26% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA MANAGEMENT INVESTMENT A... Bought 1.3 Million shares of Keryx Biopharmaceuticals ...
BALYASNY ASSET MANAGEMENT LLC Bought 1.1 Million shares of Keryx Biopharmaceuticals ...